DK2379734T3 - Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A - Google Patents

Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A Download PDF

Info

Publication number
DK2379734T3
DK2379734T3 DK09795862.3T DK09795862T DK2379734T3 DK 2379734 T3 DK2379734 T3 DK 2379734T3 DK 09795862 T DK09795862 T DK 09795862T DK 2379734 T3 DK2379734 T3 DK 2379734T3
Authority
DK
Denmark
Prior art keywords
fermentation culture
streptococcus pneumoniae
molecular weight
fermentation
hours
Prior art date
Application number
DK09795862.3T
Other languages
English (en)
Inventor
Jean Heather Crinean
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK2379734T3 publication Critical patent/DK2379734T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Claims (11)

1
1. Fremgangsmåde til fremstilling af en opløsning indeholdende isolerede kapselpolysaccharider med høj molekylvægt af typen Streptococcus pneumoniae serotype 19A, hvor fremgangsmåden omfatter: a) at fremstille en fermenteringskultur af Streptococcus pneumoniae-bakterieceller, der producerer kapselpolysaccharider serotype 19A; b) at fermentere fermenteringskulturen i mindre end 6 timer; c) at lysere bakteriecellerne i fermenteringskulturen; og d) at isolere kapselpolysaccharider af typen Streptococcus pneumoniae serotype 19A fra fermenteringskulturen, hvor det isolerede kapselpolysaccharid med høj molekylvægt af typen Streptococcus pneumoniae serotype 19A har en molekylvægt på mindst 480 kD.
2. Fremgangsmåde ifølge krav 1, der yderligere omfatter tilførsel af CO2 til fermenteringskulturen.
3. Fremgangsmåde ifølge krav 2, hvor tilførslen af CO2 til fermenteringskulturen omfatter tilsætning af bicarbonation (HCO3') til fermenteringskulturen.
4. Fremgangsmåde ifølge krav 3, hvor tilsætningen af HCO3' til fermenteringskulturen omfatter tilsætning af NaHC03.
5. Fremgangsmåde ifølge krav 2, hvor tilførslen af CO2 til fermenteringskulturen omfatter tilsætning af bicarbonation (CO32') til fermenteringskulturen.
6. Fremgangsmåde ifølge krav 5, hvor tilsætningen af CO32' til fermenteringskulturen omfatter tilsætning af Na2CC>3.
7. Fremgangsmåde ifølge krav 2, hvor tilsætning af CO2 til fermenteringskulturen omfatter en første tilsætning af NaHCC>3 og en anden tilsætning af Na2CC>3.
8. Fremgangsmåde ifølge krav 2, hvor tilførslen af CO2 til fermenteringskulturen omfatter overdækning af fermenteringskulturen med CO2. 2
9. Fremgangsmåde ifølge et af kravene 1 til 8, hvor fermenteringskulturen fermenteres i mindre end 5 timer.
10. Fremgangsmåde ifølge et af kravene 1 til 8, hvor fermenteringskulturen fermenteres i mindre end 4 timer.
11. Fremgangsmåde ifølge et af kravene 1 til 8, hvor fermenteringskulturen fermenteres i mellem 3 timer og mindre end 6 timer.
DK09795862.3T 2008-12-18 2009-12-17 Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A DK2379734T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13856308P 2008-12-18 2008-12-18
PCT/US2009/068429 WO2010080486A2 (en) 2008-12-18 2009-12-17 Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight

Publications (1)

Publication Number Publication Date
DK2379734T3 true DK2379734T3 (da) 2018-04-23

Family

ID=42266457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09795862.3T DK2379734T3 (da) 2008-12-18 2009-12-17 Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A

Country Status (19)

Country Link
US (1) US8795689B2 (da)
EP (1) EP2379734B1 (da)
JP (1) JP5843612B2 (da)
KR (2) KR20110091546A (da)
CN (1) CN102257155B (da)
AU (1) AU2009335826B2 (da)
BR (1) BRPI0922981A8 (da)
CA (1) CA2743710C (da)
DK (1) DK2379734T3 (da)
ES (1) ES2666698T3 (da)
HK (1) HK1163750A1 (da)
HU (1) HUE037465T2 (da)
IL (1) IL213169A (da)
MX (1) MX2011006432A (da)
PL (1) PL2379734T3 (da)
PT (1) PT2379734T (da)
RU (1) RU2511404C2 (da)
SI (1) SI2379734T1 (da)
WO (1) WO2010080486A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046859T2 (hu) * 2008-12-18 2020-03-30 Wyeth Llc Eljárás Streptococcus pneumoniae poliszacharid molekulatömegének szabályozására szén alkalmazásával
BRPI1014494A2 (pt) 2009-04-30 2016-08-02 Coley Pharm Group Inc vacina pneumocócica e usos da mesma
MX348547B (es) * 2011-12-15 2017-06-19 Serum Inst India Ltd Nuevo proceso para cultivar bacterias para el mejoramiento del rendimiento de las poliosas capsulares.
EP2894225B1 (en) 2012-09-07 2017-11-22 SK Chemicals Co., Ltd. Production method for capsular polysaccharide having pneumococcal serotype
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CN118662649A (zh) 2016-12-30 2024-09-20 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
US11197921B2 (en) 2017-01-31 2021-12-14 Merck Sharp & Dohme Corp. Methods for making polysaccharide-protein conjugates
WO2018156491A1 (en) 2017-02-24 2018-08-30 Merck Sharp & Dohme Corp. Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugates
US10688170B2 (en) 2017-06-10 2020-06-23 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
JP7218358B2 (ja) 2017-09-07 2023-02-06 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎球菌多糖体および免疫原性多糖体-キャリアタンパク質コンジュゲートでのその使用
CA3074703A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
TWI725359B (zh) 2017-12-06 2021-04-21 美商默沙東藥廠 包含肺炎鏈球菌多醣-蛋白結合物之組合物及其使用方法
KR20190121713A (ko) * 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
EP3788143B1 (en) 2018-04-30 2023-06-28 Merck Sharp & Dohme LLC Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
US20210252125A1 (en) 2018-04-30 2021-08-19 Merck Sharp & Dohme Corp. Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
JOP20210148A1 (ar) 2018-12-19 2023-01-30 Merck Sharp & Dohme تركيبات تشتمل على متقارنات بولي سكاريد-بروتين للمكورات العقدية الرئوية وطرق استخدامها
JP2023537945A (ja) 2020-08-10 2023-09-06 インベントプライズ・インコーポレイテッド 出現血清型24fを含む多価肺炎球菌複合糖質ワクチン

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1115210A (en) 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4221906A (en) 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4242501A (en) 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
FR2495939B1 (fr) 1980-12-11 1985-10-11 Merieux Inst Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
BE889979A (fr) 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
US5714354A (en) 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
PT1268844E (pt) * 2000-03-16 2009-11-03 Philadelphia Children Hospital Modulação da produção de polissacáridos capsulares de pneumococos
US6743610B2 (en) 2001-03-30 2004-06-01 The University Of Chicago Method to produce succinic acid from raw hydrolysates
ITTS20010013A1 (it) 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
ATE460498T1 (de) 2003-09-11 2010-03-15 Staat Der Nederlanden Vert Doo Verfahren zur herstellung eines kapselpolysaccharids zur verwendung in konjugat- impfstoffen
EP2425855A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
DK3466982T3 (da) * 2005-04-08 2020-08-03 Wyeth Llc Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
GB0522303D0 (en) * 2005-11-01 2005-12-07 Chiron Srl Culture method
ATE473289T1 (de) 2006-10-10 2010-07-15 Wyeth Llc Verbesserte verfahren zur trennung von streptococcus pneumoniae-3-polysacchariden
US7860500B2 (en) * 2006-10-27 2010-12-28 Motorola, Inc. Method and apparatus for determining appropriate channels for communication
CA2681570C (en) * 2007-03-23 2016-05-03 Wyeth Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
HUE046859T2 (hu) 2008-12-18 2020-03-30 Wyeth Llc Eljárás Streptococcus pneumoniae poliszacharid molekulatömegének szabályozására szén alkalmazásával

Also Published As

Publication number Publication date
CA2743710C (en) 2017-01-24
IL213169A (en) 2015-02-26
EP2379734A2 (en) 2011-10-26
ES2666698T3 (es) 2018-05-07
IL213169A0 (en) 2011-07-31
WO2010080486A3 (en) 2010-11-04
PL2379734T3 (pl) 2018-08-31
EP2379734B1 (en) 2018-03-21
PT2379734T (pt) 2018-04-27
HUE037465T2 (hu) 2018-09-28
RU2511404C2 (ru) 2014-04-10
MX2011006432A (es) 2011-09-29
BRPI0922981A8 (pt) 2019-11-26
AU2009335826A1 (en) 2010-07-15
KR20130136011A (ko) 2013-12-11
JP5843612B2 (ja) 2016-01-13
KR20110091546A (ko) 2011-08-11
CA2743710A1 (en) 2010-07-15
BRPI0922981A2 (pt) 2015-08-25
SI2379734T1 (en) 2018-05-31
RU2011128564A (ru) 2013-01-27
CN102257155B (zh) 2016-03-02
KR101593770B1 (ko) 2016-02-15
US20100158953A1 (en) 2010-06-24
WO2010080486A2 (en) 2010-07-15
US8795689B2 (en) 2014-08-05
CN102257155A (zh) 2011-11-23
JP2012512660A (ja) 2012-06-07
AU2009335826B2 (en) 2013-10-31
HK1163750A1 (zh) 2012-09-14

Similar Documents

Publication Publication Date Title
US11376315B2 (en) Method for controlling Streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
DK2379734T3 (da) Fremgangsmåde til at styre molekylvægten af polysaccharid af streptococcus pneumoniae serotype 19A
DK1866342T3 (da) Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
US8652480B2 (en) Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides
TWI545192B (zh) 用於製備肺炎鏈球菌血清型之莢膜多醣的方法